Jeff Korentur
Jeff Korentur is a CEO of Teewinot Life Sciences.
False
Advertisement
A View From the Biosynthetic Bridge
June 21, 2017
Regulations in the US make cannabis research highly challenging. Could biosynthetic approaches to cannabinoid production prompt regulators to rethink?
1 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
